clinical trial · NCT07160790
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
Non-erosive Gastroesophageal Reflux DiseaseJP-1366 + placeboPlacebo + Placebo
brief summary
This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD
started
Sep 2, 2025
primary completion
Jun 30, 2026
completion
Jun 30, 2026
last updated
Sep 8, 2025
official title
Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux(NERD) Disease: Double-blind, Randomized
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol